Literature DB >> 15121813

Prehospital thrombolysis--calculated health benefit for catchment population of one hospital.

Mark Kroese1, David Kanka, Peter Weissberg, Barbara Arch, John Scott.   

Abstract

The health benefit of thrombolysis in acute myocardial infarction is greatest when patients are treated soon after onset of symptoms. One approach to reducing treatment delay is to give thrombolysis before the patient reaches hospital. When an ambulance trust proposed a prehospital thrombolysis service, local commissioners requested an estimate of its possible health impact. Clinical audit and ambulance trust data were obtained for 165 patients who received thrombolysis for acute myocardial infarction in the coronary care unit of a local hospital in one year. This information was then used to estimate the health impact of prehospital thrombolysis in the local population in a mathematical model derived from the results of trials comparing prehospital and hospital thrombolysis. The best predicted local health benefit from the proposed prehospital thrombolysis service is that, if 45 minutes can be cut off the call-to-needle time, 61 cases of acute myocardial infarction need to be treated to save one additional life at 35 days. By use of published research data, the health benefits of prehospital thrombolysis can be estimated for a local population. Variables in the treatment population and ambulance service will influence the size of the health benefit that can be achieved.

Entities:  

Mesh:

Year:  2004        PMID: 15121813      PMCID: PMC1079463          DOI: 10.1177/014107680409700506

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  26 in total

1.  Community thrombolysis in the Coromandel region. Audit of the "Cardiac Events in the Coromandel-Assessment Strategy and Triage" (CE-COAST) pilot program.

Authors:  C Nunn; J Lennane; G Marriott; D Wilson
Journal:  N Z Med J       Date:  2001-05-11

2.  Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction.

Authors:  G I Barbash; A Roth; H Hod; H I Miller; M Modan; S Rath; Y H Zahav; A Shachar; S Basan; A Battler
Journal:  Am J Cardiol       Date:  1990-08-01       Impact factor: 2.778

3.  Effect of prehospital thrombolysis on aborting acute myocardial infarction.

Authors:  E J Lamfers; T E Hooghoudt; A Uppelschoten; P W Stolwijk; F W Verheugt
Journal:  Am J Cardiol       Date:  1999-10-15       Impact factor: 2.778

Review 4.  Prehospital thrombolysis: an idea whose time has come.

Authors:  C P Cannon; A J Sayah; R M Walls
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

5.  Milwaukee Prehospital Chest Pain Project--phase I: feasibility and accuracy of prehospital thrombolytic candidate selection.

Authors:  T P Aufderheide; M H Keelan; G E Hendley; N A Robinson; T E Hastings; R F Lewin; H F Hewes; A Daniel; D Engle; B K Gimbel
Journal:  Am J Cardiol       Date:  1992-04-15       Impact factor: 2.778

6.  Prehospital thrombolysis in acute myocardial infarction.

Authors:  J Schofer; J Büttner; G Geng; K Gutschmidt; H N Herden; D G Mathey; H P Moecke; P Polster; A Raftopoulo; F H Sheehan
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

7.  Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics.

Authors:  David K Pedley; Kim Bissett; Elizabeth M Connolly; Carol G Goodman; Ian Golding; T H Pringle; G P McNeill; S D Pringle; M C Jones
Journal:  BMJ       Date:  2003-07-05

8.  Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.

Authors:  L Wallentin; P Goldstein; P W Armstrong; C B Granger; A A J Adgey; H R Arntz; K Bogaerts; T Danays; B Lindahl; M Mäkijärvi; F Verheugt; F Van de Werf
Journal:  Circulation       Date:  2003-07-07       Impact factor: 29.690

9.  Prehospital thrombolysis in acute myocardial infarction: the Belgian eminase prehospital study (BEPS). BEPS Collaborative Group.

Authors: 
Journal:  Eur Heart J       Date:  1991-09       Impact factor: 29.983

Review 10.  Where are we today? Early results from MINAP, the National Audit of Myocardial Infarction Project.

Authors:  J Birkhead
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.